Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
General and administrative $ 2,291,646 $ 2,116,266
Research and development 1,749,128 1,096,286
Loss from operations (4,040,774) (3,212,552)
Other income:    
Change in fair value of warrant liabilities 26,716 (46,870)
Interest and dividends, net 153,218 (6,388)
Other income (expense), net 179,934 (53,258)
Loss before income taxes (3,860,840) (3,265,810)
Provision for income taxes
Net loss from continuing operations (3,860,840) (3,265,810)
Net loss from discontinued operations, net of tax (271,869)
Net loss $ (3,860,840) $ (3,537,679)
Weighted-average common shares outstanding, basic (in Shares) 1,042,479 1,303,652
Basic loss per share from continuing operations (in Dollars per share) $ (3.7) $ (2.6)
Basic loss per share from discontinuing operations (in Dollars per share) $ (0.2)
Comprehensive loss:    
Net loss $ (3,860,840) $ (3,537,679)
Foreign currency translation (620) (2,483)
Comprehensive loss $ (3,861,460) $ (3,540,162)